PMID- 11782486 OWN - NLM STAT- MEDLINE DCOM- 20020531 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 277 IP - 17 DP - 2002 Apr 26 TI - Regulation of mesangial cell hexokinase activity and expression by heparin-binding epidermal growth factor-like growth factor: epidermal growth factors and phorbol esters increase glucose metabolism via a common mechanism involving classic mitogen-activated protein kinase pathway activation and induction of hexokinase II expression. PG - 14370-8 AB - Heparin-binding epidermal growth factor -like growth factor (HB-EGF) expression and hexokinase (HK) activity are increased in various pathologic renal conditions. Although the mitogenic properties of HB-EGF have been well characterized, its effects on glucose (Glc) metabolism have not. We therefore examined the possibility that HB-EGF might regulate HK activity and expression in glomerular mesangial cells, which constitute the principal renal cell type affected by a variety of pathologic conditions. Protein kinase C (PKC)-dependent classic mitogen-activated protein kinase (MAPK) pathway activation has been associated with increased HK activity in this cell type, so we also examined dependence upon these signaling intermediates. HB-EGF (> or =10 nm) increased total HK activity over 50% within 12-24 h, an effect mimicked by other EGF receptor agonists, but not by IGF-1 or elevated Glc. EGF receptor and classic MAPK pathway antagonists prevented this increase, as did general inhibitors of gene transcription and protein synthesis. Both HB-EGF and phorbol esters activated the classic MAPK pathway, albeit via PKC-independent and PKC-dependent mechanisms, respectively. Both stimuli were associated with increased HK activity, selectively increased HKII isoform expression, and increased Glc metabolism via both the glycolytic-tricarboxylic acid cycle route and the pentose phosphate pathway. HB-EGF thus constitutes a novel regulator of mesangial cell HK activity and Glc metabolism. HKII is the principal regulated isoform in these cells, as it is in insulin-sensitive peripheral tissues, such as muscle. However, the uniform requirement for classic MAPK pathway activation distinguishes HKII regulation in mesangial cells from that observed in muscle. These findings suggest a novel mechanism whereby growth factors may couple metabolism to glomerular injury. FAU - Robey, R Brooks AU - Robey RB AD - Department of Medicine, University of Illinois at Chicago College of Medicine, Chicago, Illinois 60612, USA. RBRobey@uic.edu FAU - Ma, Jianfei AU - Ma J FAU - Santos, Anna V P AU - Santos AV FAU - Noboa, Oscar A AU - Noboa OA FAU - Coy, Platina E AU - Coy PE FAU - Bryson, Jane M AU - Bryson JM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20020108 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Enzyme Inhibitors) RN - 0 (Flavonoids) RN - 0 (Hbegf protein, mouse) RN - 0 (Heparin-binding EGF-like Growth Factor) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Isoenzymes) RN - 0 (Ligands) RN - 42HK56048U (Tyrosine) RN - 62229-50-9 (Epidermal Growth Factor) RN - 67763-96-6 (Insulin-Like Growth Factor I) RN - EC 2.7.1.1 (Hexokinase) RN - EC 2.7.11.13 (Protein Kinase C) RN - IY9XDZ35W2 (Glucose) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) RN - SJE1IO5E3I (2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one) SB - IM MH - Animals MH - Cell Line MH - Enzyme Induction MH - Enzyme Inhibitors/pharmacology MH - Epidermal Growth Factor/*physiology MH - Flavonoids/pharmacology MH - Glomerular Mesangium/*enzymology MH - Glucose/*metabolism MH - Heparin-binding EGF-like Growth Factor MH - Hexokinase/biosynthesis/chemistry/genetics/*metabolism MH - Immunohistochemistry MH - Insulin-Like Growth Factor I/physiology MH - Intercellular Signaling Peptides and Proteins MH - Isoenzymes/biosynthesis/chemistry/genetics/metabolism MH - Ligands MH - *MAP Kinase Signaling System MH - Mice MH - Oxidation-Reduction MH - Phosphorylation MH - Protein Kinase C/metabolism MH - Tetradecanoylphorbol Acetate/*pharmacology MH - Tyrosine/metabolism EDAT- 2002/01/10 10:00 MHDA- 2002/06/01 10:01 CRDT- 2002/01/10 10:00 PHST- 2002/01/10 10:00 [pubmed] PHST- 2002/06/01 10:01 [medline] PHST- 2002/01/10 10:00 [entrez] AID - S0021-9258(19)60811-2 [pii] AID - 10.1074/jbc.M111722200 [doi] PST - ppublish SO - J Biol Chem. 2002 Apr 26;277(17):14370-8. doi: 10.1074/jbc.M111722200. Epub 2002 Jan 8.